K Sandahl1, L B Nielsen1, J Svensson1, J Johannesen1,2, F Pociot1,2, H B Mortensen1,2, P Hougaard3, R Broe4,5,6, M L Rasmussen4,5,6, J Grauslund4,5,6, T Peto4,7, B S Olsen1. 1. Department of Paediatrics, Herlev Hospital, University of Copenhagen, Herlev, Denmark. 2. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. 3. Department of Epidemiology, Biostatistics and Biodemography, Odense University Hospital, Odense, Denmark. 4. Department of Ophthalmology, Odense University Hospital, Odense, Denmark. 5. The Clinical Research Institute, University of Southern Denmark, Odense, Denmark. 6. OPEN Odense Patient data Explorative Network, Odense University Hospital, Odense, Denmark. 7. NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
Abstract
AIM: To determine the mortality rate in a Danish cohort of children and adolescents diagnosed with Type 1 diabetes mellitus compared with the general population. METHODS: In 1987 and 1989 we included 884 children and 1020 adolescents aged 20 years and under, corresponding to 75% of all Danish children and adolescents with Type 1 diabetes, in two nationwide studies in Denmark. Those who had participated in both investigations (n = 720) were followed until 1 January 2014, using the Danish Civil Registration System on death certificates and emigration. We derived the expected number of deaths in the cohort, using population data values from Statistics Denmark to calculate the standardized mortality ratio. Survival analysis was performed using Cox proportional hazards model. RESULTS: During the 24 years of follow-up, 49 (6.8%) patients died, resulting in a standardized mortality ratio of 4.8 (95% confidence interval 3.5, 6.2) compared with the age-standardized general population. A 1% increase in baseline HbA1c (1989), available in 718 of 720 patients, was associated with all-cause mortality (hazard ratio = 1.38; 95% confidence interval 1.2, 1.6; P < 0.0001). Type 1 diabetes with multiple complications was the most common reported cause of death (36.7%). CONCLUSION: We found an increased mortality rate in this cohort of children and adolescents with Type 1 diabetes compared with the general population. The only predictor for increased risk of death up to 24 years after inclusion was the HbA1c level in 1989. This emphasizes the importance of achieving optimal metabolic control in young people with Type 1 diabetes.
AIM: To determine the mortality rate in a Danish cohort of children and adolescents diagnosed with Type 1 diabetes mellitus compared with the general population. METHODS: In 1987 and 1989 we included 884 children and 1020 adolescents aged 20 years and under, corresponding to 75% of all Danish children and adolescents with Type 1 diabetes, in two nationwide studies in Denmark. Those who had participated in both investigations (n = 720) were followed until 1 January 2014, using the Danish Civil Registration System on death certificates and emigration. We derived the expected number of deaths in the cohort, using population data values from Statistics Denmark to calculate the standardized mortality ratio. Survival analysis was performed using Cox proportional hazards model. RESULTS: During the 24 years of follow-up, 49 (6.8%) patients died, resulting in a standardized mortality ratio of 4.8 (95% confidence interval 3.5, 6.2) compared with the age-standardized general population. A 1% increase in baseline HbA1c (1989), available in 718 of 720 patients, was associated with all-cause mortality (hazard ratio = 1.38; 95% confidence interval 1.2, 1.6; P < 0.0001). Type 1 diabetes with multiple complications was the most common reported cause of death (36.7%). CONCLUSION: We found an increased mortality rate in this cohort of children and adolescents with Type 1 diabetes compared with the general population. The only predictor for increased risk of death up to 24 years after inclusion was the HbA1c level in 1989. This emphasizes the importance of achieving optimal metabolic control in young people with Type 1 diabetes.
Authors: Joseph E O'Reilly; Luke A K Blackbourn; Thomas M Caparrotta; Anita Jeyam; Brian Kennon; Graham P Leese; Robert S Lindsay; Rory J McCrimmon; Stuart J McGurnaghan; Paul M McKeigue; John A McKnight; John R Petrie; Sam Philip; Naveed Sattar; Sarah H Wild; Helen M Colhoun Journal: Diabetologia Date: 2020-05-26 Impact factor: 10.122
Authors: Joanna Parkinson; Weifeng Tang; Magnus Åstrand; Johanna Melin; Ella Ekholm; Bengt Hamrén; David W Boulton Journal: Diabetes Obes Metab Date: 2019-03-14 Impact factor: 6.577
Authors: Jesus Dominguez-Riscart; Nuria Buero-Fernandez; Ana Garcia-Zarzuela; Celia Morales-Perez; Ana Garcia-Ojanguren; Alfonso M Lechuga-Sancho Journal: Front Nutr Date: 2022-03-04